The Lancet HIV in conversation with
By The Lancet Group
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by The Lancet Group
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 7
Reviews: 0
Episodes: 68
Description
Peter Hayward, Editor-in-Chief, and Adrian Gonzalez-Lopez, Senior Editor at The Lancet HIV, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from treatments of children with HIV to COVID-19 and chemsex, the experiences of HIV among global Indigenous populations to intimate partner violence and women with HIV, and more.
| Episode | Date |
|---|---|
|
Drew Voetsch and Robert Selato on achieving the 95-95-95 UNAIDS goals in Botswana
|
Apr 09, 2024 |
|
Adam Trickey on trends in causes of death among people with HIV in Europe and North America
|
Feb 27, 2024 |
|
Manik Kohli, Iain Reeves, and Laura Waters on homophobia in the provision of sexual health care in the UK
|
Jan 29, 2024 |
|
Lulu Nair, Connie Celum, and Kenneth Ngure on dapivirine vaginal ring and daily oral PrEP for HIV prevention in women
|
Nov 29, 2023 |
|
Sophia Rein on HIV treatment with INSTIs and cardiovascular events
|
Nov 01, 2023 |
|
Lawrence Mbuagbaw on reporting of HIV drug resistance in clinical studies using the CEDRIC-HIV checklist
|
Oct 05, 2023 |
|
Andreas Jahn and Nellie Wadonda-Kabondo on trends in HIV prevalence and incidence
|
Sep 01, 2023 |
|
Eryn Braley and Mckenzie Braley on experiences of HIV among global Indigenous populations
|
Aug 11, 2023 |
|
Ricardo Luque and Miguel Barriga on HIV prevalence and care continuum among migrants from Venezuela in Colombia (en Español)
|
Jul 06, 2023 |
|
Denton Callander on the effects of treatment as prevention
|
Jun 01, 2023 |
|
Andrea Wirtz and Sari Reisner on HIV incidence and mortality among transgender women
|
May 04, 2023 |
|
Yasmin Mohamed on early infant diagnosis of HIV
|
Apr 13, 2023 |
|
Salome Kuchukhidze and Francisco Mbofana on intimate partner violence and women with HIV
|
Feb 01, 2023 |
|
Lise Jamieson and Gesine Mayer-Rath on cabotegravir for PrEP in South Africa
|
Dec 14, 2022 |
|
Helen Ayles and Musonda Simwinge on the PopART trial
|
Nov 07, 2022 |
|
Carol Strong and Stephane Ku on HIV and chemsex
|
Sep 28, 2022 |
|
Elijah Kakande and Gabriel Chamie on TB interventions for people with HIV
|
Aug 30, 2022 |
|
Amir Mohareb on PrEP and hepatitis B
|
Jul 26, 2022 |
|
Kenneth Ngure on PrEP in Kenya
|
Jul 01, 2022 |
|
Marta Vasylyev and Casper Rokx on HIV care for displaced Ukranians
|
May 31, 2022 |
|
Angela Colbers and Hylke Waalewijn on treatment for children with HIV
|
May 03, 2022 |
|
Nabila El-Bassel on intimate partner violence and HIV
|
Mar 01, 2022 |
|
Amy Justice on ageing with HIV
|
Feb 23, 2022 |
|
Bridget Mugisa on the epidemiology of HIV in the Middle East and north Africa
|
Feb 01, 2022 |
|
Aaloke Mody and Izukanji Sikazwe on universal HIV treatment in Zambia
|
Nov 29, 2021 |
|
José Miro and Juliana Reyes on COVID-19 in people living with HIV
|
Nov 01, 2021 |
|
Jon Shuter on smokers with HIV
|
Sep 27, 2021 |
|
Elizabeth Marie King on menopausal hormone therapy
|
Aug 31, 2021 |
|
John Frater on COVID-19 vaccination and HIV
|
Aug 03, 2021 |
|
Elias Dah on PrEP in west Africa
|
Jun 28, 2021 |
|
Fatima Mir on the 2019 HIV outbreak in Pakistan
|
Jun 01, 2021 |
|
Jessica Castilho and Claudia Cortes on HIV life expectancy in Latin America and the Caribbean
|
Apr 26, 2021 |
|
Chloe Orkin on long-acting cabotegravir
|
Mar 29, 2021 |
|
Sarah Calabrese on U=U
|
Mar 01, 2021 |
|
Le Minh Giang and Todd Korthuis on opioid use disorder and HIV in Vietnam
|
Feb 01, 2021 |
|
Michael Herce, Tonia Poteat, Ward van Bilsen and Hanne Zimmerman, and Jade Pagkas-Bather
|
Dec 08, 2020 |
|
Mathebe Kopo and Alain Amstutz on HIV testing and the HOSENG trial
|
Oct 28, 2020 |
|
Susannah Mayhew on integrating sexual health and HIV services
|
Sep 30, 2020 |
|
Ankur Gupta-Wright and Melanie Alufandika-Moyo on HIV drug resistance in Malawi
|
Sep 04, 2020 |
|
Di Gibb and Anna Turkova on dolutegravir for children with HIV
|
Aug 04, 2020 |
|
Chi-Chi Udeagu on the impact of COVID-19 on HIV in NYC
|
Jul 01, 2020 |
|
Kelly Dooley and Gavin Churchyard on TB prevention in people with HIV
|
Jun 03, 2020 |
|
The London Patient on being cured of HIV
|
May 04, 2020 |
|
Point-of-care viral load testing
|
Apr 01, 2020 |
|
HIV transmission dynamics in Rakai, Uganda
|
Mar 05, 2020 |
|
HIV and influenza vaccine
|
Feb 12, 2020 |
|
Living well with HIV
|
Dec 04, 2019 |
|
HIV vaccines
|
Oct 29, 2019 |
|
Risk prediction and prevention
|
Sep 30, 2019 |
|
Third-line therapy
|
Sep 04, 2019 |
|
Assessing the safety of a PrEP intravaginal ring
|
Jul 30, 2019 |
|
Safer conception for couples living with HIV
|
Jul 03, 2019 |
|
Integrated care for key populations
|
May 02, 2019 |
|
Tackling drug use to improve ART adherence
|
Apr 03, 2019 |
|
Measuring adherence to PrEP
|
Jan 07, 2019 |
|
Paediatric HIV in 2018
|
Dec 01, 2018 |
|
PrEP in New South Wales
|
Oct 27, 2018 |
|
HIV outbreak in Indiana
|
Sep 17, 2018 |
|
Internet-based intervention for people with HIV and depressive symptoms
|
Sep 07, 2018 |
|
Enhanced treatment and prevention in sex workers
|
Aug 07, 2018 |
|
HIV-2
|
Jul 03, 2018 |
|
Potential non-disclosed MSM in UK HIV networks
|
Jun 05, 2018 |
|
Journal expansion and early treatment of infants with HIV
|
May 02, 2018 |
|
Universal test and treat: The Lancet HIV: November 30, 2017
|
Dec 01, 2017 |
|
PrEP in African women: The Lancet HIV: October 31, 2017
|
Oct 31, 2017 |
|
HIV disparity modelling: The Lancet HIV: April 18, 2017
|
Apr 19, 2017 |
|
HIV in transgender women in Brazil: The Lancet HIV: February 7, 2017
|
Feb 08, 2017 |
|
World AIDS Day 2015
|
Dec 02, 2015 |